Healthcare -
Biotechnology - NASDAQ - US
$ 0.7132
1.86 %
$ 36.9 M
Market Cap
-1.04
P/E
XLO - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities XLO - Xilio Therapeutics, Inc.
29.2 M
LAST VALUE
1961.87%
2 YEAR CAGR
-13.42%
5 YEAR CAGR
0.00%
10 YEAR CAGR